A threshold‐free summary index for quantifying the capacity of covariates to yield efficient treatment rules
暂无分享,去创建一个
Paul Gustafson | Mohsen Sadatsafavi | Mohammad Ali Mansournia | P. Gustafson | M. Sadatsafavi | Mohammad Ali Mansournia
[1] David M Kent,et al. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal , 2010, Trials.
[2] John Connett,et al. Azithromycin for prevention of exacerbations of COPD. , 2011, The New England journal of medicine.
[3] S D Walter,et al. The partial area under the summary ROC curve , 2005, Statistics in medicine.
[4] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[5] J. Gastwirth. The Estimation of the Lorenz Curve and Gini Index , 1972 .
[6] D. Rubin. Comment: Which Ifs Have Causal Answers , 1986 .
[7] Arthur E. Hoerl,et al. Ridge Regression: Biased Estimation for Nonorthogonal Problems , 2000, Technometrics.
[8] R. Tibshirani,et al. Regression shrinkage and selection via the lasso: a retrospective , 2011 .
[9] Peter Bühlmann. Regression shrinkage and selection via the Lasso: a retrospective (Robert Tibshirani): Comments on the presentation , 2011 .
[10] I. van der Tweel,et al. Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes , 2016, BMC Medical Research Methodology.
[11] J. Wedzicha,et al. COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.
[12] P. Gustafson,et al. Relative impact characteristic curve: a graphical tool to visualize and quantify the clinical utility and population-level consequences of implementing markers. , 2018, Annals of epidemiology.
[13] Matthew M. Chingos,et al. The Review of Economics and Statistics , 2018 .
[14] Ewout W. Steyerberg,et al. Overfitting and optimism in prediction models , 2009 .
[15] S. Greenland,et al. Limitations of individual causal models, causal graphs, and ignorability assumptions, as illustrated by random confounding and design unfaithfulness , 2015, European Journal of Epidemiology.
[16] Ewout W Steyerberg,et al. The proposed 'concordance-statistic for benefit' provided a useful metric when modeling heterogeneous treatment effects. , 2018, Journal of clinical epidemiology.
[17] Lu Tian,et al. Effectively Selecting a Target Population for a Future Comparative Study , 2013, Journal of the American Statistical Association.
[18] Ewout W Steyerberg,et al. Models with interactions overestimated heterogeneity of treatment effects and were prone to treatment mistargeting. , 2019, Journal of clinical epidemiology.
[19] William White,et al. A Proposal , 2008, Moon, Sun, and Witches.
[20] Ewout Steyerberg,et al. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects , 2018, British Medical Journal.
[21] C. Begg,et al. Using the Lorenz Curve to Characterize Risk Predictiveness and Etiologic Heterogeneity. , 2016, Epidemiology.
[22] S. Taylor,et al. Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly. , 2015, The American journal of medicine.
[23] C. Metz. Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.
[24] E. Elkin,et al. Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[25] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[26] A. Mushlin,et al. Focusing Technology Assessment Using Medical Decision Theory , 1988, Medical decision making : an international journal of the Society for Medical Decision Making.
[27] Stephen W Lagakos,et al. Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.
[28] F. Martinez,et al. American Journal of Epidemiology Practice of Epidemiology the Association between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: an Application of a Joint Frailty-logistic Model , 2022 .
[29] D. Rubin. Statistics and Causal Inference: Comment: Which Ifs Have Causal Answers , 1986 .
[30] N. Obuchowski,et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.
[31] K Claxton,et al. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.
[32] Tyler J. VanderWeele,et al. Selecting Optimal Subgroups for Treatment Using Many Covariates , 2018, Epidemiology.
[33] M. J. van der Laan,et al. Statistical Applications in Genetics and Molecular Biology Super Learner , 2010 .